122 related articles for article (PubMed ID: 38507936)
1. HLA-class-I expression loss, tumor microenvironment and breast cancer prognosis.
Giatromanolaki A; Michos GD; Xanthopoulou E; Koukourakis MI
Cell Immunol; 2024; 399-400():104816. PubMed ID: 38507936
[TBL] [Abstract][Full Text] [Related]
2. Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
Sinn BV; Weber KE; Schmitt WD; Fasching PA; Symmans WF; Blohmer JU; Karn T; Taube ET; Klauschen F; Marmé F; Schem C; Stickeler E; Ataseven B; Huober J; von Minckwitz G; Seliger B; Denkert C; Loibl S
Breast Cancer Res; 2019 Dec; 21(1):142. PubMed ID: 31829264
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers.
Tsang JY; Ho CS; Ni YB; Shao Y; Poon IK; Chan SK; Cheung SY; Shea KH; Marabi M; Tse GM
Cancer Immunol Immunother; 2020 May; 69(5):799-811. PubMed ID: 32055918
[TBL] [Abstract][Full Text] [Related]
4. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.
de Groot AF; Blok EJ; Charehbili A; Engels CC; Smit VTHBM; Dekker-Ensink NG; Putter H; Meershoek-Klein Kranenbarg E; van de Velde CJH; Liefers GJ; Nortier JWR; Kuppen PJK; van der Burg SH; Kroep JR
Breast Cancer Res Treat; 2019 Jun; 175(3):605-615. PubMed ID: 30868392
[TBL] [Abstract][Full Text] [Related]
5. Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer.
Nakayama Y; Mimura K; Tamaki T; Shiraishi K; Kua LF; Koh V; Ohmori M; Kimura A; Inoue S; Okayama H; Suzuki Y; Nakazawa T; Ichikawa D; Kono K
Int J Oncol; 2019 Jun; 54(6):2030-2038. PubMed ID: 31081058
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.
Imai D; Yoshizumi T; Okano S; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Soejima Y; Aishima S; Oda Y; Maehara Y
Cancer Med; 2017 Jul; 6(7):1614-1626. PubMed ID: 28602029
[TBL] [Abstract][Full Text] [Related]
7. Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism.
Koukourakis IM; Giatromanolaki A; Mitrakas A; Koukourakis MI
Cell Immunol; 2022 Mar; 373():104495. PubMed ID: 35183853
[TBL] [Abstract][Full Text] [Related]
8. Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.
Gil-Julio H; Perea F; Rodriguez-Nicolas A; Cozar JM; González-Ramirez AR; Concha A; Garrido F; Aptsiauri N; Ruiz-Cabello F
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298868
[TBL] [Abstract][Full Text] [Related]
9. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
Giatromanolaki A; Gkegka AG; Pouliliou S; Biziota E; Kakolyris S; Koukourakis M
Breast Cancer Res Treat; 2022 Jul; 194(1):13-23. PubMed ID: 35482128
[TBL] [Abstract][Full Text] [Related]
11. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
12. NK Cell Infiltrates and HLA Class I Expression in Primary HER2
Muntasell A; Rojo F; Servitja S; Rubio-Perez C; Cabo M; Tamborero D; Costa-García M; Martínez-Garcia M; Menéndez S; Vazquez I; Lluch A; Gonzalez-Perez A; Rovira A; López-Botet M; Albanell J
Clin Cancer Res; 2019 Mar; 25(5):1535-1545. PubMed ID: 30523021
[TBL] [Abstract][Full Text] [Related]
13. Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8
Abd Hamid M; Wang RZ; Yao X; Fan P; Li X; Chang XM; Feng Y; Jones S; Maldonado-Perez D; Waugh C; Verrill C; Simmons A; Cerundolo V; McMichael A; Conlon C; Wang X; Peng Y; Dong T
Cancer Immunol Res; 2019 Aug; 7(8):1293-1306. PubMed ID: 31213473
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of HLA class I expression in breast cancer.
Kaneko K; Ishigami S; Kijima Y; Funasako Y; Hirata M; Okumura H; Shinchi H; Koriyama C; Ueno S; Yoshinaka H; Natsugoe S
BMC Cancer; 2011 Oct; 11():454. PubMed ID: 22014037
[TBL] [Abstract][Full Text] [Related]
15. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
Georgiannos SN; Renaut A; Goode AW; Sheaff M
Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
[TBL] [Abstract][Full Text] [Related]
16. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
[TBL] [Abstract][Full Text] [Related]
17. Differential prognostic impact of CD8
Kwak Y; Koh J; Park Y; Hong YJ; Park KU; Kim HH; Park DJ; Ahn SH; Kim WH; Lee HS
Br J Cancer; 2020 Apr; 122(9):1399-1408. PubMed ID: 32203213
[TBL] [Abstract][Full Text] [Related]
18. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Kass R; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD
Breast Cancer Res Treat; 2003 Aug; 80(3):275-85. PubMed ID: 14503800
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy.
Saraiva DP; Jacinto A; Borralho P; Braga S; Cabral MG
Front Immunol; 2018; 9():2605. PubMed ID: 30555458
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
Ogasawara M; Rosenberg SA
Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
